Longevity Health Holdings Implements Stock Restructuring
Longevity Health Holdings, Inc. (NASDAQ: XAGE), a prominent name in the bio-aesthetics sector focusing on longevity and healthy aging, recently announced a significant corporate action: a reverse stock split of 1-for-30 for its common stock.
Details of the Reverse Stock Split
The initiative, aimed at optimizing the company’s stock performance, had received unanimous approval from stockholders at a special meeting. This meeting, which took place earlier this year, permitted the board of directors to set the reverse stock split's precise ratio and timing.
Effective Date and Trading Changes
The reverse stock split became effective on May 12, 2025, at 9:00 a.m. Eastern Time. Starting from May 14, 2025, trading on the Nasdaq Capital Market will be adjusted, with shares trading under the existing symbol "XAGE". Investors will notice a change in their share holdings, whereby every thirty shares will be consolidated into one, dramatically reducing the total outstanding share count from around 30.1 million to approximately 1 million shares.
Impact on Shareholders
For shareholders, this reverse split will not result in fractional shares; any fractions arising from the conversion will be rounded up to the nearest whole share. The company’s transfer agent will facilitate this process seamlessly for stockholders holding shares in various forms, including electronically in book-entry form.
Understanding the Corporate Strategy
This strategic move is designed to enhance the market perception of Longevity’s stock and provide better alignment with other firms in the industry. It is a tactical attempt to fortify the company’s capital structure in response to market conditions and investor sentiment.
Company Overview
Longevity Health Holdings, Inc. is dedicated to delivering innovative products in the health and aesthetic fields. With two main lines of cosmetic products, Carmell Secretome™ and Elevai Exosomes™, Longevity aims to combat the signs of aging by promoting skin and hair health. Their offerings cater to both professional care providers and retail consumers, sold across multiple channels in the United States.
Future Prospects and Adjustments
As a part of this restructuring, proportional adjustments will be made to outstanding stock options and warrants, ensuring that equity remains fair across all holders of securities. This adjustment also applies to the shares allocated under the company’s 2023 Equity Incentive Plan.
Conclusion and Outlook
The reverse stock split is just one part of Longevity Health Holdings' ongoing strategy to strengthen its position within the bio-aesthetic market. As the company advances its goals, it will continue to explore innovative solutions that align with current market trends and the needs of its customers.
Frequently Asked Questions
What is the reason for the reverse stock split by Longevity Health Holdings?
The reverse stock split aims to improve the market perception of the company's stock and streamline its capital structure.
What happens to my shares after the reverse stock split?
For each 30 shares you hold before the split, you will receive 1 new share, rounding up any fractions to the nearest whole share.
When did the reverse stock split take effect?
The reverse stock split took effect on May 12, 2025.
Will this affect the stock options and warrants?
Yes, there will be proportional adjustments made to stock options and warrants as part of the reverse stock split.
Who can I contact for more information about my shares?
For further inquiries, you may reach out to Bryan Cassaday at bcassaday@healthxage.com.
